InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Kendall Keith J, Chairman & CEO. Insider active across 1 companies, notably Aquestive Therapeutics, Inc.. Aggregated, 2 filings have been recorded. Regulator: SEC (Form 4). All data is free.
Declarations2 total
1,000 shares
Common Stock
SEC:0001214659-21-009051·
1,000 shares
Common Stock
SEC:0001214659-21-009051:0·
2 of 2 declarations
About Kendall Keith J
Keith J. Kendall is the Chief Executive Officer of Aquestive Therapeutics, Inc. He leads the company with a strategic vision focused on innovation and product quality. His leadership is essential for the growth and competitiveness of the organization.
